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Adult body height is a quantitative trait for which genome-wide association studies (GWAS) have identified
numerous loci, primarily in European populations. These loci, comprising common variants, explain <10% of
the phenotypic variance in height. We searched for novel associations between height and common (minor
allele frequency, MAF ≥5%) or infrequent (0.5% < MAF < 5%) variants across the exome in African Americans.
Using a reference panel of 1692 African Americans and 471 Europeans from the National Heart, Lung, and
Blood Institute’s (NHLBI) Exome Sequencing Project (ESP), we imputed whole-exome sequence data into 13
719 African Americans with existing array-based GWAS data (discovery). Variants achieving a height-
association threshold of P < 5E206 in the imputed dataset were followed up in an independent sample of
1989 African Americans with whole-exome sequence data (replication). We used P < 2.5E207 (50.05/196 779
variants) to define statistically significant associations in meta-analyses combining the discovery and replica-
tion sets (N 5 15 708). We discovered and replicated three independent loci for association: 5p13.3/C5orf22/
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rs17410035 (MAF 5 0.10, b 5 0.64 cm, P 5 8.3E208), 13q14.2/SPRYD7/rs114089985 (MAF 5 0.03, b 5 1.46 cm,
P 5 4.8E210) and 17q23.3/GH2/rs2006123 (MAF 5 0.30; b 5 0.47 cm; P 5 4.7E209). Conditional analyses sug-
gested 5p13.3 (C5orf22/rs17410035) and 13q14.2 (SPRYD7/rs114089985) may harbor novel height alleles inde-
pendent of previous GWAS-identified variants (r2 with GWAS loci <0.01); whereas 17q23.3/GH2/rs2006123
was correlated with GWAS-identified variants in European and African populations. Notably, 13q14.2/
rs114089985 is infrequent in African Americans (MAF 5 3%), extremely rare in European Americans (MAF 5
0.03%), and monomorphic in Asian populations, suggesting it may be an African-American-specific height
allele. Our findings demonstrate that whole-exome imputation of sequence variants can identify low-frequency
variants and discover novel variants in non-European populations.
INTRODUCTION
Adult body height is a classic quantitative trait that involves
numerous genetic loci (1). Because it is greatly determined by
genetics (narrow-sense heritability h2  0.75–0.9) (2–4) and
is generally stable and well measured, height serves as a model
for gaining insight into the genetic architecture of complex
traits. Genome-wide association studies (GWAS) have identi-
fied hundreds of height-associated variants (1,5–23). These
loci combined, however, explain only 10% of the phenotypic
variation—suggesting many height-related variants remain
unidentified (1). As GWAS are designed to capture common
(.5%) genetic variation, identifying less frequent or rare var-
iants that confer larger genetic effects may help account in part
for the unexplained genetic component of height (24,25).
Whole-exome sequencing technology facilitates the compre-
hensive examination of genetic variation in or near protein-
coding regions of the genome (26,27). These regions may
harbor low-frequency variants with biological consequences
that carry larger effects. For instance, exome sequencing has
been used to identify rare variants that cause highly penetrant
Mendelian disorders (28–30). For complex quantitative traits,
however, detecting associations with low-frequency variation
has been challenging as large populations must be sequenced,
which is prohibitively expensive. This limitation can be
addressed in part by using exome sequencing followed by imput-
ation of sequence variants into those with existing genome-wide
single nucleotide polymorphism (SNP) array data (31)—which
increases the effective number of individuals with exome data
and in turn increases statistical power. Recent studies have suc-
cessfully applied this approach to identify novel low-frequency
variants that contribute to phenotypic differences in complex
traits, such as those related to blood cells (31) and von Wille-
brand factor (32).
The majority of height loci have been identified in European
populations (1); however, GWAS conducted in Asian
populations, including Chinese (7,14,16), Korean (9,14), Japa-
nese (11) and Filipino (8), have reported height loci previously
unidentified in European descent individuals (9,11). Similarly,
two large GWAS in African Americans (5,6) replicated
several height loci identified in European populations, but also
reported three novel loci (2p14/ANTXR1, 17q23/TMEM100/
PCTP and Xp22.3/ARSE). These data suggest some variants
may be more common in non-European populations, which
increases statistical power to identify certain height-related
loci in these populations. African Americans show increased
genomic diversity and overall lower linkage disequilibrium
(LD) patterns compared with European and Asian populations
(33). Applying exome sequencing in this population can help
identify novel height-related variants and fine-map regions har-
boring GWAS-identified variants, which can help refine likely
causal variant(s) and provide insight into the genetic basis of
height and other complex traits (34–37).
In this study, we searched for novel genetic variants related to
adult body height in African Americans by imputing exome
sequence data from the National Heart, Lung, and Blood Insti-
tute’s (NHLBI) Exome Sequencing Project (ESP) into 13 719
individuals with previously collected array-based GWAS data.
In African Americans, imputation using ESP data outperformed
imputation using 1000 Genomes Project data (38). We replicated
variants showing the strongest associations in 1989 African
Americans with whole-exome sequencing data. Using this com-
bination of imputed and directly sequenced exome data, we exam-
ined comprehensively both common and less frequent genetic
variation in or near protein-coding regions in relation to height.
RESULTS
Table 1 shows the mean age and height, by sex, for 15 708 African
Americans in the study population. For participants in the Candi-
date Gene Association Resource (CARe) and Women’s Health
Table 1 Age and height, separated by sex, for 15 708 African Americans included in the study population
Discovery set Replication set
CARe WHI-SHARe ESP
Female Male Female Male Female Male
N 3778 2422 7519 0 1501 488
Age (years)a 49.9 (14.4) 50.3 (14.8) 61.7 (7.1) – 57.5 (10.4) 53.2 (13.8)
Height (cm)a 163.4 (6.5) 176.7 (6.8) 162.5 (6.2) – 162.5 (6.5) 176.1 (7.2)
aValues are mean (SD).
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Initiative (WHI) SNP Health Association Resource (WHI-
SHARe) cohorts, whole-exome association tests with height
showed 35SNPs (in 12 loci)withdiscoveryP , 5E206(Supple-
mentary Material, Table S1); these variants were subsequently
carried forward for replication in ESP samples. We identified
eight SNPs in three loci (5p13.3, 13q14.2 and 17q23.3) with rep-
lication P-values close to 0.05 and a statistically significant
combined (discovery + replication) P-value (P , 2.5E207)
(Table 2). 13q14.2 and 17q23.3 each harbored more than one
height association signal (Fig. 1). At each locus, we conditioned
on the most strongly associated SNP (13q14.2/SPRYD7/rs1140
89985 and 17q23.3/GH2/rs2006123), and tested the remaining
SNPs for association one-by-one. No additional SNPs at either
locus demonstrated evidence for association in the conditional
analyses, suggesting three independent signals [5p13.3 (C5orf
22/rs17410035: MAF¼ 0.10, b¼ 0.64, P¼ 8.3E208), 13q14.2
(SPRYD7/rs114089985: MAF¼ 0.03, b¼ 1.46, P¼ 4.8E210)
and 17q23.3 (GH2/rs2006123: MAF ¼ 0.30; b ¼ 0.47; P ¼
4.7E209)] (bolded in Table 2).
In 17q23.3, rs2006123 and rs7223078 is located 523 kb apart
and show weak correlation (Fig. 1C). After conditioning on rs20
06123, the association with rs7223078 was slightly attenuated
(P ¼ 3.6E206 to 8.5E204); likewise, after conditioning on
rs7223078, the association with rs2006123 became weaker
(P ¼ 1.6E207 to 4.2E205), but did not vanish. This suggests
the possibility that multiple alleles contribute to height in
17q23.3.
GWAS have previously identified height-related variants in
5p13.3 (1,13,23) and 13q14.2 (1,20,23) in individuals of Euro-
pean ancestry, and in 17q23.3 in those of European (1,23) and
African (5,6) ancestry. In 5p13.3, however, the distance
between rs17410035 and the nearest GWAS SNP (rs645092)
is 1.1 Mb; the association for rs17410035 remained very
similar after conditioning on GWAS-identified SNPs in this
locus (rs6450922, rs3792752 and rs1173727) (Supplementary
Material, Table S2), suggesting that rs17410035 is independ-
ent of previously identified GWAS findings. In 13q14.2,
rs114089985 has a MAF of 3% in African Americans (Exome
Variant Server allele count: A ¼ 38/G ¼ 1346), but is extremely
rare in European Americans (Exome Variant Server allele count:
A ¼ 1/G ¼ 3181; MAF ¼ 0.03%), and is monomorphic in
Asian populations (1000 Genomes Project CHB + CHS +
JPT allele count: A ¼ 0/G ¼ 572). As expected, in African
ancestry individuals rs114089985 showed minimal correlation
(r2 , 0.2) with SNPs identified in European populations
(rs3116602, rs3118905 and rs9596219) and conditional analyses
did not alter the association (Supplementary Material, Table S2).
In 17q23.3, conditioning on three GWAS-identified SNPs
(rs7209435, rs2854160 and rs2941551), but not rs2665838, sub-
stantially attenuated the association with rs2006123 (Supple-
mentary Material, Table S2). This, again, may suggest the
existence of multiple effect alleles at this locus, including at
least one allele tagged by rs2006123 and three of the GWAS var-
iants. Alternatively, it is also possible that this set of modestly
correlated SNPs tags a single causal variant that has not been
genotyped or is poorly imputed.
It is important to note that our finding in 5p13.3/C5orf22
should be interpreted with caution as locus-specific ancestry
showed a statistically significant association with height at this
locus (P ¼ 2.3E203). After additional adjustment for local T
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ancestry, the association with rs17410035 was slightly attenu-
ated (before: b ¼ 0.59, P ¼ 4.1E206; after: b ¼ 0.53, P ¼
1.1E204) (Table 3). In contrast, in 13q14.2/SPRYD7, local
ancestry was not associated with height (P ¼ 7.0E201), and
additional adjustment did not alter the association with
rs114089985 (before: b ¼ 1.42, P¼ 2.1E209; after: b¼ 1.42,
Figure 1 Regional association plots of height association signals in combined CARe + WHI-SHARe + ESP meta-analysis. Each dot reflects the 2log10 P-value of
one SNP in the region. The purple diamond indicates the index SNP showing an association signal. The color of the other dots reflects correlation (r2) with the
height-related SNP based on the 1000 Genomes Project African populations. Axes: left Y-axis shows 2log10 of P-values; X-axis shows SNP genomic position
based on NCBI build 37; and right Y-axis shows the estimated recombination rate from the 1000 Genomes Project African populations.
Table 3 Association results for height-related variants after adjusting for local ancestry in 13 719 African Americans in CARe and WHI-SHARe
Chr Positiona SNP Gene Function
class
Effect
allele
Other
allele
MAF Mean
Rsq
CARe + WHI-SHARe
before adjustmentb
CARe + WHI-SHARe
after adjustmentc
bd SE P bd SE P
5p13.3 31541142 rs17410035 C5orf22 Intron T G 0.10 0.97 0.59 0.13 4.1E206 0.53 0.14 1.1E204
13q14.2 50501743 rs114089985 SPRYD7 Intron A G 0.03 0.94 1.42 0.24 2.1E209 1.42 0.24 2.5E209
17q23.3 61958669 rs2006123 GH2 Intron T G 0.30 0.97 0.44 0.08 1.6E207 0.28 0.09 2.9E203
SNP, single nucleotide polymorphism; Ref, reference allele; Alt, alternate allele; MAF, minor allele frequency; Rsq, imputation quality.
aBased on NCBI build 37 data.
bAdjusted for age, sex, study and global ancestry (the first two principal components).
cAdjusted for age, sex, study, global ancestry (the first two principal components) and local ancestry.
dEstimate calculated using the additive genetic model for each additional effect allele.
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P¼ 2.5E209). In 17q23.3/GH2, local ancestry was associated
with height (P ¼ 1.6E204). After adjustment for local ancestry,
the association was attenuated for rs2006123 (before: b ¼ 0.44,
P ¼ 1.6E207; after: b ¼ 0.28, P ¼ 2.9E203).
When investigating previous GWAS-identified height loci in
our study, genotype data were available for only 10 of these
height-related SNPs in our study as most of the 200 GWAS-
identified height-related SNPs are intronic or intergenic. For
these 10 variants, 8 showed P-values ≤ 0.05 (Supplementary
Material, Table S3). Further, b-estimates for 9 of the 10 SNPs
showed directions consistent with previous findings.
DISCUSSION
We discovered and replicated eight SNPs in three loci (5p13.3,
13q14.2 and 17q23.3) that showed statistically significant
height-associations after correction for multiple testing. These
corresponded to three independent association signals: 5p13.3/
C5orf22, 13q14.2/SPRYD7 and 17q23.3/GH2. After conditioning
on GWAS-identified SNPs in 5p13.3 and 13q14.2, we identified
two potential novel alleles (C5orf22/rs17410035 and SPRYD7/
rs114089985) associated with height in African Americans.
After additional adjustment for local ancestry, however, the
height association with rs17410035 was slightly attenuated,
suggesting this relation should be interpreted cautiously and
requires confirmation in other study populations.
C5orf22/rs17410035 is common in both African Americans
(MAF ¼ 0.10) and European populations (MAF ¼ 0.30), and
possesses a proxy SNP (r2 ¼ 1) genotyped on existing genome-
wide arrays. It is therefore unclear why previous GWAS did not
detect this variant. In over 180 000 individuals of European
ancestry, for instance, rs17410035 showed P ¼ 2.3E205
(effect estimates were unavailable in public GIANT Consortium
GWAS data) (1) (Supplementary Material, Fig. S1). One possi-
bility is that the effect size in other populations is more modest
than that observed in our study, necessitating even larger
sample sets than that in the largest studies across populations
(1,6,11). Another possibility is that, in African Americans,
rs17410035 tags a different causal variant or is a better tag for
the true causal variant. Finally, heterogeneity of effects across
different study populations might also help explain the differ-
ence in findings. In contrast, SPRYD7/rs114089985 is infrequent
in African Americans (MAF ¼ 3%), extremely rare in European
Americans (MAF ¼ 0.03%), and monomorphic in Asian popu-
lations—suggesting this variant may be a population-specific
allele undetected in studies conducted in non-African popula-
tions. Consistent with the hypothesis that low-frequency vari-
ation may confer larger effects (25), in our population, each
rs114089985-A allele corresponded to a 1.46 cm increase in
height (0.2 SD). Despite this large effect size, however,
rs114089985 was undetected in GWAS conducted in large
African-American populations (5,6), likely because it was not
identified in HapMap, not genotyped on previous genome-wide
arrays, and did not possess a strong proxy (r2 best proxy SNP ¼
0.43). In our study, imputation of exome sequence variants
enabled the analysis of many low-frequency SNPs missed on
previous genotyping arrays. These findings emphasize the im-
portance of using these data to study low-frequency variants,
which are less likely to be in LD with GWAS-identified variants
(25), and to analyze non-European populations.
Although conditional analysis showed 17q23.3/GH2/
rs2006123 was not independent of several GWAS-identified
SNPs (1,5,6,23), in CARe and WHI-SHARe combined,
rs2006123 (P ¼ 1.6E207) showed a smaller P-value compared
with the GWAS variants (rs7209435, P ¼ 3.1E207; rs2665838,
P ¼ 7.7E201; rs2854160, P ¼ 4.7E205; rs2941551,
P ¼ 5.2E203) (Supplementary Material, Fig. S2), suggesting
this SNP and rs7209435 may better tag the underlying functional
variant. Whereas annotation by available bioinformatics sources
(39–43) did not identify putative functions for these GWAS
SNPs, including rs7209435, rs2006123 perfectly tags (r2 ¼ 1)
several variants located within a secondary promoter for GH2
(growth hormone 2, 400 bp upstream of the transcription
start site). Specifically, rs2955250, rs60832412 and rs5821405
are located within a region exhibiting open chromatin that
showed histone modifications consistent with promoter and en-
hancer activity in several cell lines. In addition, these variants are
located within a binding site for many transcription factors (e.g.
MAFK, RUNX3, EGR1, RAD21 and CTCF). It is important to
note, however, that bioinformatics-based annotation is intended
to help identify biologically plausible functional candidates,
and laboratory studies are needed to yield definitive evidence
of the mechanisms driving SNP associations with height.
Adjustment for locus-specific ancestry resulted in a slight at-
tenuation of the association in 5p13.3/C5orf22 and did not alter
the association in 13q14.2/SPRYD7; however, adjustment for
local ancestry greatly attenuated the association in 17q23.3/
GH2. These results are consistent with admixture mapping ana-
lyses in African Americans (5), which suggested regions on
chromosome 17 may harbor variants that affect height and also
show large allele frequency differences between European and
African ancestral populations.
This study is the first to use exome imputation of sequence
variants to examine frequent as well as less frequent variation
in relation to height in African Americans. As we aimed to
increase statistical power to comprehensively investigate
exonic genetic variation, we imputed exome sequence variants
into those with existing genome-wide SNP array data. Imputed
genotypes can be called with varying accuracy, and we
accounted for this using the genotype dosage, which yields un-
biased effect size estimates (44). However, lower imputation ac-
curacy may attenuate the estimated significance of association
signals (45,46). In our study we observed good overall imput-
ation accuracy as the information retained [estimated average
dosage r2, calculated using the squared Pearson correlation
between imputed and experimental genotypes from the Metabo-
chip (47)] was 80%, even for low-frequency variants (see Sup-
plementary Material, Methods for additional details). In a recent
publication, we found that an imputation reference panel con-
structed from the ESP sequence data alone outperformed one
constructed from the 1000 Genomes Project for imputation of
rare-coding variants into African-American populations. The
gain in imputation accuracy relative to 1000 Genomes was
found for variants with MAF ,1% (38).
The largest GWAS to date has reported hundreds of variants
that showed weak or modest effects on height (1). Given this
genetic architecture, limited statistical power may haveaccounted
for the absence of rare height-related signals. For common genetic
variants (allele frequency ¼ 20%), the present analysis had 80%
power to detect a per-allele change in height of 0.65 cm; for
Human Molecular Genetics, 2014, Vol. 23, No. 24 6611
rare variants (allele frequency ¼ 1%), there was 80% power to
detect a per-allele change in height of 2.6 cm (0.4 SD) (Supple-
mentary Material, Fig. S3). These estimates suggest that our data
provided sufficient statistical power to detect less common SNPs
with large effect sizes in regions with reasonably high imputation
quality (Rsq¼ 0.80). However, it is notable that we found strong
evidence for only one novel height-related allele (13q14.2/
SPRYD7/rs114089985) and moderate evidence for another
(5p13.3/C5orf22/rs17410035). These data emphasize that much
larger populations are likely needed to detect remaining height
associations with less frequent, but imputable, coding vari-
ation—particularly for variants with more modest associations.
Finally, our study primarily tested for associations with genetic
variation in protein-coding regions of the genome and provided
minimal coverage of variants in non-coding regions. It remains
important to study these, however, as 88% of GWAS-identified
variants for various diseases and traits have been located in non-
coding regions (48), and these variants likely serve important
regulatory purposes in the cell (40,41). This is supported by data
in the present analysis showing that, even when using imputed
exome sequence data, seven of the eight statistically significant
variants were either intronic or intergenic.
In this African-American population, we used a combination
of genome-wide SNP array and imputed whole-exome sequence
data to comprehensively examine both common and less fre-
quent variation in or near protein-coding regions of the genome.
We identified two potentially novel height-related alleles in
5p13.3 (C5orf22/rs17410035) and 13q14.2 (SPRYD7/rs114089
985), one of which (rs114089985) was uncommon and African
American-specific. These findings warrant further study and
show that whole-exome imputation of sequence variants is an
effective strategy to investigate low-frequency variation as
well as identify novel genetic associations in non-European
populations.
MATERIALS AND METHODS
Study population
The discovery study population included 13 719 self-identified
African Americans with GWAS data from five population-based
cohort studies. This comprised 6200 participants from the
NHLBI CARe consortium (Atherosclerosis Risk in Communi-
ties Study, ARIC; Coronary Artery Risk Development in
Young Adults, CARDIA; Multi-Ethnic Study of Atheroscler-
osis, MESA and Jackson Heart Study, JHS), and 7519 partici-
pants from the WHI-SHARe project. The replication set
included an independent population of 1989 individuals of
African ancestry who underwent whole-exome sequencing as
part of the NHLBI ESP as described previously (included
studies can be found in Supplementary Material, Methods and
by going to https://esp.gs.washington.edu/drupal/) (49–51).
Study-specific descriptions and details are provided in Supple-
mentary Material, Methods. Height in centimeters was collected
by in-person examination, and clinical information was col-
lected by self-report and in-person examination. We excluded
participants missing height data (N ¼ 5 in CARe, 44 in WHI-
SHARe, 898 in ESP). All participants provided written informed
consent as approved by local human-subjects committees.
Genome-wide genotyping and quality control
Genome-wide genotyping and quality control (QC) procedures
have been described (31) and are available in the Supplementary
Material, Methods. Briefly, DNA was genotyped using Affyme-
trix 6.0 arrays (Affymetrix, Santa Clara, CA, USA). CARe con-
ducted a candidate gene survey using the ITMAT/Broad/CARe
(IBC) candidate gene array in all participants, and a GWAS
(Affymetrix 6.0) only in African Americans. Genotyped SNPs
were excluded based on call rate (,98%), monomorphic
SNPs, lack of Hardy–Weinberg Equilibrium in controls (P ,
1 × 1024), and low allele frequency (MAF,1%). DNA
samples were excluded based on genotyping success rate
(,97%), duplicate discordance or sex mismatch, or genetic an-
cestry outliers as determined by principal component analysis
(52). CARe and WHI-SHARe samples were combined into a
single set for phasing using BEAGLE Version 3.3.1 (53).
Exome sequencing, variant calling and QC
Detailed information on exome sequencing, variant calling and
QC procedures is provided in the Supplementary Material,
Methods. Briefly, as part of the NHLBI ESP, whole-exome
sequencing was performed in 6823 individuals by the University
of Washington (Seattle, WA, USA) or the Broad Institute (Cam-
bridge, MA, USA). Each institute used a unified sequencing
framework that included the following steps: (i) initial QC of
sample DNA quantity and quality, (ii) library construction and
exome capture or in-solution hybrid selection, (iii) cluster amp-
lification and sequencing of enriched libraries, (iv) read mapping
and variant analysis using the Genome Analysis Toolkit (GATK,
refv1.2905) (27) and (v) evaluation of exome sequencing data
against standard QC metrics. Variants were called using the
UMAKE software pipeline provided by the University of Mich-
igan, Ann Arbor, MI, USA (http://www.sph.umich.edu/csg/ka
ng/umake/download/), which allowed all samples to be analyzed
simultaneously for variant calling and filtering. For variant-level
QC we filtered out variants that failed a set of SNP quality
metrics in a support vector machine (SVM), and those with a
read depth ,10 or .500, low call rate or lack of Hardy–
Weinberg equilibrium. For sample-level QC, we filtered out
DNA samples that exhibited relatedness based on a kinship ana-
lysis, high missing rates, high homozygosity, sex mismatch, low
concordance with genome-wide SNP array data and genetic an-
cestry outliers as determined by principal component analysis.
Genotype imputation to the ESP
Detailed information on imputation of sequence data is available
in the Supplementary Material, Methods. As the reference panel
for imputation we used the haplotypes from 1692 individuals of
African ancestry and 471 of European ancestry with whole-
exome sequence data from ESP. Study-specific reference data
from different ancestral populations help improve imputation
accuracy of low-frequency variants (54). A total of 1 077 164
autosomal SNPs, pre-phased across all 2163 samples using
BEAGLE (53), were included in the reference panel. The
target panel comprised genome-wide genotype data in WHI-
SHARe and CARe obtained using the methods described
above. The target panel was phased using BEAGLE (53), and
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the phased target panel was imputed to the ESP data using
Minimac (55). We used Rsq as the imputation quality measure
for imputed SNPs (56). Based on prior experimental validation
of imputed low-frequency variants (31), we excluded imputed
SNPs such that variants with lower MAFs required higher
imputation quality: for SNPs with MAF . 0.01, we excluded
those with Rsq ≤ 0.3; for MAFs of 0.005–0.01, we excluded
Rsq , 0.7; SNPs with MAF , 0.005 were excluded because
most of these SNPs are not imputed well, and our study had
limited statistical power to detect associations with these SNPs.
In total, we imputed 375 024 autosomal markers into WHI-
SHARe and CARe (see Supplementary Material, Methods).
After exclusion based on imputation Rsq (110 134 SNPs) and
MAF (68 111 SNPs), 196 779 imputed variants (80 438 with
MAF ≥0.05; 82 329 with MAFs of 0.01–0.05; and 34 012 with
MAF ≤0.01) remained in the dataset for association analysis.
Statistical analysis
To reduce the influence of outliers, separately in WHI-SHARe,
CARe andESP,we setallheight values belowthe 0.05th percentile
of the overall height distribution to the 0.05th percentile (N ¼ 38 in
WHI-SHARe, 28 in CARe, 29 in ESP); all values above the 99.5th
percentile were set to the 99.5th percentile (N ¼ 38 in WHI-
SHARe, 28 in CARe, 35 in ESP). Unless otherwise indicated, all
analyses were adjusted for age, sex (in CARe and ESP), study
and the first two principal components derived from EIGEN-
STRAT (52) to account for global population substructure.
Association analysis
Association tests were performed separately in WHI-SHARe
and CARe. We estimated the association between each variant
and height using multivariable linear regression assuming addi-
tive genetic effects. Each sequenced SNP was coded as 0, 1 or 2
copies of the alternate (variant) allele. For imputed variants,
we used the expected number of copies of the alternate allele
between 0 and 2 (the dosage), which gives unbiased effect
estimates (44). To combine study-specific estimates across
studies, we performed inverse-variance weighted fixed-effects
meta-analysis using METAL (57). We tested for heterogeneity
between WHI-SHARe and CARe results using Cochran’s Q sta-
tistics (58). Quantile–quantile (Q–Q) plots were used to assess
whether the distribution of P-values was consistent with the null
distribution (except for the extreme tail).
Replication of height association signals
Based on combined estimates in WHI-SHARe and CARe (the
discovery set), we selected SNPs showing P , 5E206 for rep-
lication in an independent African ancestry population with
whole-exome sequencing data. We tested for associations
between individual variants and height using multivariable
linear regression assuming additive genetic effects. This was fol-
lowed by an inverse-variance weighted fixed-effects meta-
analysis combining the association results in WHI-SHARe,
CARe and ESP (discovery + replication). To maintain an
overall Type 1 error rate of 5%, we used a conservative
Bonferroni-corrected threshold of P , 2.5E207 (¼0.05/196
779 variants) to identify statistically significant SNPs in the
combined analysis (discovery + replication).
Conditional association testing
To test whether variants in the same locus were independently
associated with height, we used conditional analyses that sim-
ultaneously included two or more variants in a single model.
When testing whether associated variants were independent of
GWAS-identified SNPs, we performed conditional analyses
only in CARe and WHI-SHARe (87% of the total study popula-
tion) as these participants had available genome-wide SNP array
as well as imputed HapMap data (59).
Adjustment for locus-specific ancestry
In recently admixed populations such as African Americans,
even within a single individual, specific genomic regions can ori-
ginate with varying frequencies from different ancestral popula-
tions (60). Recent findings in African Americans suggest this
locus-specific ancestry (i.e. local ancestry) may associate with
height on several chromosomes (5). To determine the extent to
which local ancestry affected the observed associations, we in-
ferred the ancestry of every participant at each statistically sig-
nificant SNP and additionally adjusted for these estimates in
sensitivity analyses. To estimate local ancestry, we used the
Hidden Markov model (61) implemented in genome-wide Affy-
metrix 6.0 data, as in Carty et al. (5). Local ancestry estimates
were coded as 0 ¼ two European alleles, 1 ¼ one European/
one African allele, 2 ¼ two African alleles at each GWAS
SNP. At each height-associated SNP, the two immediately adja-
cent local ancestry estimates were always identical. Thus, we
used these as the estimated local ancestry at each height-
associated SNP. We regressed height on the SNP of interest,
local ancestry, age, sex, study and global ancestry based on the
first two principal components. Local ancestry-adjusted ana-
lyses were limited to CARe and WHI-SHARe (the discovery
set) as these participants had available GWAS data.
We used R (Version 2.15.1, R Foundation for Statistical Com-
puting, Vienna, Austria) to conduct the statistical analysis, and
LocusZoom (62) to visualize results. To determine the
minimum detectable effect estimates in the present analysis,
we estimated statistical power using Quanto Version 1.2.4
(http://hydra.usc.edu/gxe/).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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